Drug Development

ICON Announces Clinical Research partnership with DuPage Medical Group

21st May 2018

ICON plc , a global provider of drug development and commercialisation solutions and services, announced that PMG Research, Inc., part...

Regeneron and Sanofi Share First Positive Clinical Data for Cemiplimab in Advanced Non-small Cell Lung Cancer at ASCO

by Content Team

21st May 2018

Regeneron Pharmaceuticals, Inc. and Sanofi announced that the first positive Phase 1 clinical data assessing cemiplimab as a potential treatment...

Lupin’s Nagpur facility US FDA inspection concluded with no observations

by Content Team

21st May 2018

Pharma major Lupin announced the successful completion of an inspection carried out by the US FDA at its Nagpur facility....

U.S. FDA Approves Expanded Indication for Truvada for Reducing the Risk of Acquiring HIV-1 in Adolescents

by Content Team

21st May 2018

Gilead Sciences, Inc. announced that the U.S. FDA has approved once-daily oral Truvada® (emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)—in...

Teva Announces Publication of Phase III Trial Data of Fremanezumab for the Preventive Treatment of Episodic Migraine in the Journal of the American Medical Association

by Content Team

21st May 2018

Teva Pharmaceutical Industries Ltd. announced the publication of data from the Phase III HALO study evaluating the efficacy, safety, and...

CIMZIA is The First Therapy to Demonstrate Positive Results in a 52-week, Placebo Controlled Non-Radiographic Axial Spondyloarthritis Study

by Content Team

21st May 2018

UCB announced positive topline results from C-AXSPAND, a Phase 3 placebo controlled study to investigate the efficacy of CIMZIA® (certolizumab...

Zymeworks and Daiichi Sankyo Expand Immuno-Oncology Collaboration Focused on Bispecific Antibodies

by Content Team

21st May 2018

Zymeworks Inc. , a clinical-stage biopharmaceutical company developing multifunctional therapeutics, and Daiichi Sankyo Company, Limited announced that they entered into...